Riken Vitamin Co Ltd
Riken Vitamin Co Ltd is a Japanese manufacturer and distributor of vitamins, food additives, and pharmaceutical ingredients, generating revenue primarily through the sale of these products to food, beverage, and pharmaceutical companies.
Business. Riken Vitamin Co Ltd (4526.T) is a food processing company operating within the Food & Beverages industry. The firm is headquartered in Japan and is primarily listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Riken Vitamin Co Ltd (4526.T) is a food processing company operating within the Food & Beverages industry. The firm is headquartered in Japan and is primarily listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Riken Vitamin Co Ltd maintains a strong liquidity position, with a current ratio of 3.11 and cash and equivalents of ¥22.3 billion, which provides a buffer against short-term obligations. The company's debt-to-equity ratio of 0.14 indicates a conservative capital structure, with long-term debt of ¥11.1 billion compared to total equity of ¥79.2 billion. Free cash flow of ¥5.01 billion supports operational flexibility and potential reinvestment.
Profitability metrics show a return on equity (ROE) of 11.86% and a return on assets (ROA) of 8.31%, both exceeding the typical thresholds for the Food Processing industry. The gross profit margin of 32.7% and operating margin of 7.99% suggest efficient cost management and pricing power relative to industry norms.
The company's revenue is concentrated in its core Food Processing segment, with no disclosed geographic diversification beyond Japan. This concentration may expose the company to regional economic fluctuations and regulatory changes, though the domestic market remains stable.
Looking ahead, Riken Vitamin Co Ltd is projected to maintain stable revenue growth, with analysts forecasting ¥96 billion in revenue for the current fiscal year, compared to actual revenue of ¥95.6 billion. The company's operating cash flow of ¥7.89 billion and free cash flow of ¥5.01 billion support its ability to sustain operations and fund future growth.
The company's risk profile is low, with no immediate liquidity or dilution flags detected. The low dilution risk is supported by the absence of recent share issuance or shelf registration activity. The company's conservative capital structure and strong cash position further reduce financial risk.
Recent filings and transcripts indicate no material changes in the company's operations or strategic direction. The company continues to focus on its core business of vitamin and food additive production, with no disclosed major capital projects or acquisitions in the latest reporting period.
- Riken Vitamin Co Ltd maintains a conservative capital structure with a low debt-to-equity ratio of 0.14 and strong liquidity.
- The company's profitability metrics, including ROE of 11.86% and ROA of 8.31%, are robust and exceed industry norms.
- Revenue is concentrated in the Food Processing segment, with no disclosed geographic diversification beyond Japan.
- Analysts forecast stable revenue growth, with a mean estimate of ¥96 billion for the current fiscal year.
- The company's risk profile is low, with no immediate liquidity or dilution flags detected.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 213,55 |
| Revenue | —no estimate | —no estimate | 96,0B JPY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Riken Vitamin Co Ltd Market data — financials · 2026-05-26
- Riken Vitamin Co Ltd Market data — analyst estimates · 2026-05-26